Trauma and Cardiometabolic Health in an American Indian Community
IHPIPO'TO'TSP
2 other identifiers
interventional
400
1 country
1
Brief Summary
Volunteers for the study are asked to participate in two laboratory sessions. In the first laboratory session, volunteers are asked to provide a blood sample which will be used to measure factors related to health. Participants also complete questionnaires related to demographic and health-related information and undergo evaluations of their body composition. In the second laboratory visit, participants are asked to have cardiovascular, neuroendocrine, and inflammatory activity measured during a brief period of rest and during a short challenging psychological task. Participants will also complete questionnaires. The study is designed to examine the associations between experiences such as trauma and resiliency with changes in bodily systems during a challenge and current health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2024
CompletedFirst Submitted
Initial submission to the registry
January 10, 2025
CompletedFirst Posted
Study publicly available on registry
March 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
March 17, 2025
March 1, 2025
3.1 years
January 10, 2025
March 10, 2025
Conditions
Outcome Measures
Primary Outcomes (23)
Changes in systolic blood pressure activity from baseline to task
The mean systolic blood pressure (mmHg) will be subtracted from the mean of the task period.
10 minute resting baseline mean will be subtracted from the 4 minute task period for each value
Changes in diastolic blood pressure activity from baseline to task
The mean diastolic blood pressure (mmHg) will be subtracted from the mean of the task period.
10 minute resting baseline mean will be subtracted from the 4 minute task period for each value
Changes in heart rate activity from baseline to task
The mean heart rate (bpm) will be subtracted from the mean of the task period.
10 minute resting baseline mean will be subtracted from the 4 minute task period for each value
Change in cortisol from baseline to task
Salivary samples will be taken to measure cortisol (nmol/L) the mean from the peak stress period will be subtracted from the baseline
Baseline will be subtracted from the peak (15 minutes after task onset, 35 minute task onset)
Changes in IL-6 from baseline to task
IL-6 (pg/mL) measured at baseline will be subtracted from the IL-6 measured post task.
Baseline will be subtracted from the level 30 minutes after task onset.
Pulse wave velocity
Pulse wave velocity in m/s will be assessed by dual impedance cardiography as a non-invasive indicator of arterial stiffness. This measure will be derived from the 5 minute baseline period.
5 minutes
Resting systolic blood pressure
Resting systolic blood pressure (mmHg)
10 minutes
Resting diastolic blood pressure
Resting diastolic blood pressure (mmHg)
10 minutes
Inflammatory and anti-inflammatory cytokines
Circulating levels of C-reactive protein, interleukin-6, tumor necrosis factor-a, monocyte chemoattractant protein-1, interleukin-1b, interleukin-10, and adiponectin will be assessed via a blood draw. A composite score will be created.
5 minutes
Hemoglobin A1c
Hemoglobin A1c (nmol/L) will be assessed via blood draw
5 minutes
Glucose
Glucose (nmol/L) will be assessed via blood draw
5 minutes
Insulin
Insulin (mL) will be assessed via blood draw
5 minutes
Cholesterol
Total cholesterol (mg) will be assessed via blood draw
5 minutes
Low-density lipoprotein
Low-density lipoprotein (mg/dL) will be assessed via blood draw
5 minutes
High-density lipoprotein
high-density lipoprotein (mg/dL) will be assessed via blood draw
5 minutes
Triglycerides
Triglycerides (mmol/L) will be assessed via blood draw
5 minutes
Waist circumference
Waist circumference
2 minutes
Hip circumference
Hip circumference
2 minutes
Depressive symptomology (Hospital Anxiety Depression Questionnaire depression subscale)
Hospital Anxiety Depression Questionnaire (depression subscale)
10 minutes
Depressive symptomology (PHQ-9)
PHQ-9
10 minutes
Anxiety symptomtology
Hospital Anxiety Depression Questionnaire (Anxiety subscale)
5 minutes
Alcohol use
Alcohol use will be assessed using the Alcohol Use Identification Test
10 minutes
Substance use
A cumulative score of substance use will be reported by indicating the number of recreational drugs "ever" tried
5 minutes
Study Arms (1)
Paced Auditory Serial Addition Task
EXPERIMENTALVolunteers are presented with an audio playing of single digit numbers between 1 and 9. They are instructed to add the number with the number previously presented and say the answer out loud. Volunteers are told their performance is being scored by research assistants. Volunteers are also instructed to look at themselves in a mirror while partaking in the task. Volunteers are informed they can discontinue at any time. Volunteers complete brief questionnaires before and after the task to asses their perceptions of stress, arousal, and anxiety.
Interventions
Volunteers will complete a 4-minute Paced Auditory Serial Addition Task which is a standardized laboratory challenge that is widely used to monitor cardiovascular, neuroendocrine, and inflammatory responses in the laboratory.
Eligibility Criteria
You may qualify if:
- years
- Identifying as American Indian
- Living on or near Blackfeet reservation
You may not qualify if:
- Uncontrolled hypertension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Montana State Universitylead
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
- Baylor Universitycollaborator
- Blackfeet Community Collegecollaborator
Study Sites (1)
Blackfeet Community College
Browning, Montana, 59417, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neha John-Henderson, PhD
Montana State University
- PRINCIPAL INVESTIGATOR
Annie Ginty, PhD
Baylor University
- PRINCIPAL INVESTIGATOR
Betty Henderson-Mathews, MA
Blackfeet Community College
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2025
First Posted
March 17, 2025
Study Start
May 10, 2024
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
March 17, 2025
Record last verified: 2025-03